Neuropeptide Y modulates sympathetic control of atrial contractility, inhibits noradrenaline release, and induces coronary vasoconstriction in guinea-pig hearts.
No takes yet. Share an insight, caveat, or question.
These guinea-pig findings warrant no clinical change; leaves open NPY's role in human cardiac sympathetic regulation.
Franco‐Cereceda et al. (1985) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: